Ngā hua rapu kaituhi

1

Tumor Immunology, toward a Success Story? mā Sautès-Fridman, Catherine

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

Editorial: Tertiary Lymphoid Structures: From Basic Biology to Translational Impact in Cancer mā Sautès-Fridman, Catherine, Dimberg, Anna, Verma, Vivek

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Tumor microenvironment in NSCLC suppresses NK cells function mā Cremer, Isabelle, Fridman, Wolf Herman, Sautès-Fridman, Catherine

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

The European Academy of Tumor Immunology: Bridging fields, continents and generations mā Kroemer, Guido, Fridman, Wolf Hervé, Sautès-Fridman, Catherine, Zitvogel, Laurence

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

Characteristics of tertiary lymphoid structures in primary cancers mā Goc, Jérémy, Fridman, Wolf-Herman, Sautès-Fridman, Catherine, Dieu-Nosjean, Marie-Caroline

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

Presentation of Antigen in Immune Complexes Is Boosted by Soluble Bacterial Immunoglobulin Binding Proteins mā Léonetti, Michel, Galon, Jérome, Thai, Robert, Sautès-Fridman, Catherine, Moine, Gervaise, Ménez, André

I whakaputaina 1999

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer Therapies mā Donnou, Sabrina, Galand, Claire, Touitou, Valérie, Sautès-Fridman, Catherine, Fabry, Zsuzsanna, Fisson, Sylvain

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies mā Petitprez, Florent, Meylan, Maxime, de Reyniès, Aurélien, Sautès-Fridman, Catherine, Fridman, Wolf H.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

Complement System: Promoter or Suppressor of Cancer Progression? mā Revel, Margot, Daugan, Marie V., Sautés-Fridman, Catherine, Fridman, Wolf H., Roumenina, Lubka T.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models mā Galand, Claire, Donnou, Sabrina, Molina, Thierry Jo, Fridman, Wolf Herman, Fisson, Sylvain, Sautès-Fridman, Catherine

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Trial watch: Monoclonal antibodies in cancer therapy mā Vacchelli, Erika, Eggermont, Alexander, Galon, Jérôme, Sautès-Fridman, Catherine, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Trial watch: Oncolytic viruses for cancer therapy mā Vacchelli, Erika, Eggermont, Alexander, Sautès-Fridman, Catherine, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

Trial Watch: Toll-like receptor agonists for cancer therapy mā Vacchelli, Erika, Eggermont, Alexander, Sautès-Fridman, Catherine, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses mā Goc, Jérémy, Fridman, Wolf-Herman, Hammond, Scott A, Sautès-Fridman, Catherine, Dieu-Nosjean, Marie-Caroline

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models mā Cosette, Jeremie, Ben Abdelwahed, Rym, Donnou-Triffault, Sabrina, Sautès-Fridman, Catherine, Flaud, Patrice, Fisson, Sylvain

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma mā Petitprez, Florent, Ayadi, Mira, de Reyniès, Aurélien, Fridman, Wolf H., Sautès-Fridman, Catherine, Job, Sylvie

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Trial watch: Chemotherapy with immunogenic cell death inducers mā Vacchelli, Erika, Galluzzi, Lorenzo, Fridman, Wolf Hervé, Galon, Jerome, Sautès-Fridman, Catherine, Tartour, Eric, Kroemer, Guido

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

Site-specific N-glycosylation analysis of soluble Fcγ receptor IIIb in human serum mā Yagi, Hirokazu, Takakura, Daisuke, Roumenina, Lubka T., Fridman, Wolf Herman, Sautès-Fridman, Catherine, Kawasaki, Nana, Kato, Koichi

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine mā Petitprez, Florent, Sun, Cheng-Ming, Lacroix, Laetitia, Sautès-Fridman, Catherine, de Reyniès, Aurélien, Fridman, Wolf H.

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy mā Vacchelli, Erika, Aranda, Fernando, Eggermont, Alexander, Galon, Jérôme, Sautès-Fridman, Catherine, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Sautès-Fridman, Catherine

Tumor Immunology, toward a Success Story? mā Sautès-Fridman, Catherine

Editorial: Tertiary Lymphoid Structures: From Basic Biology to Translational Impact in Cancer mā Sautès-Fridman, Catherine, Dimberg, Anna, Verma, Vivek

Tumor microenvironment in NSCLC suppresses NK cells function mā Cremer, Isabelle, Fridman, Wolf Herman, Sautès-Fridman, Catherine

The European Academy of Tumor Immunology: Bridging fields, continents and generations mā Kroemer, Guido, Fridman, Wolf Hervé, Sautès-Fridman, Catherine, Zitvogel, Laurence

Characteristics of tertiary lymphoid structures in primary cancers mā Goc, Jérémy, Fridman, Wolf-Herman, Sautès-Fridman, Catherine, Dieu-Nosjean, Marie-Caroline

Presentation of Antigen in Immune Complexes Is Boosted by Soluble Bacterial Immunoglobulin Binding Proteins mā Léonetti, Michel, Galon, Jérome, Thai, Robert, Sautès-Fridman, Catherine, Moine, Gervaise, Ménez, André

Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer Therapies mā Donnou, Sabrina, Galand, Claire, Touitou, Valérie, Sautès-Fridman, Catherine, Fabry, Zsuzsanna, Fisson, Sylvain

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies mā Petitprez, Florent, Meylan, Maxime, de Reyniès, Aurélien, Sautès-Fridman, Catherine, Fridman, Wolf H.

Complement System: Promoter or Suppressor of Cancer Progression? mā Revel, Margot, Daugan, Marie V., Sautés-Fridman, Catherine, Fridman, Wolf H., Roumenina, Lubka T.

Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models mā Galand, Claire, Donnou, Sabrina, Molina, Thierry Jo, Fridman, Wolf Herman, Fisson, Sylvain, Sautès-Fridman, Catherine

Trial watch: Monoclonal antibodies in cancer therapy mā Vacchelli, Erika, Eggermont, Alexander, Galon, Jérôme, Sautès-Fridman, Catherine, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo

Trial watch: Oncolytic viruses for cancer therapy mā Vacchelli, Erika, Eggermont, Alexander, Sautès-Fridman, Catherine, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo

Trial Watch: Toll-like receptor agonists for cancer therapy mā Vacchelli, Erika, Eggermont, Alexander, Sautès-Fridman, Catherine, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses mā Goc, Jérémy, Fridman, Wolf-Herman, Hammond, Scott A, Sautès-Fridman, Catherine, Dieu-Nosjean, Marie-Caroline

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models mā Cosette, Jeremie, Ben Abdelwahed, Rym, Donnou-Triffault, Sabrina, Sautès-Fridman, Catherine, Flaud, Patrice, Fisson, Sylvain

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma mā Petitprez, Florent, Ayadi, Mira, de Reyniès, Aurélien, Fridman, Wolf H., Sautès-Fridman, Catherine, Job, Sylvie

Trial watch: Chemotherapy with immunogenic cell death inducers mā Vacchelli, Erika, Galluzzi, Lorenzo, Fridman, Wolf Hervé, Galon, Jerome, Sautès-Fridman, Catherine, Tartour, Eric, Kroemer, Guido

Site-specific N-glycosylation analysis of soluble Fcγ receptor IIIb in human serum mā Yagi, Hirokazu, Takakura, Daisuke, Roumenina, Lubka T., Fridman, Wolf Herman, Sautès-Fridman, Catherine, Kawasaki, Nana, Kato, Koichi

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine mā Petitprez, Florent, Sun, Cheng-Ming, Lacroix, Laetitia, Sautès-Fridman, Catherine, de Reyniès, Aurélien, Fridman, Wolf H.

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy mā Vacchelli, Erika, Aranda, Fernando, Eggermont, Alexander, Galon, Jérôme, Sautès-Fridman, Catherine, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo

Ngā utauta rapu: